This website requires Javascript for some parts to function properly. Your experience may vary.
Skip to content
0"
x-effect="if (searchOpen) { $nextTick(() => (window.matchMedia('(min-width: 64rem)').matches ? $refs.searchInputDesktop : $refs.searchInputMobile)?.focus()) }"
@keyup.escape.window="if (searchOpen) { searchOpen = false } else if (mobileSubnavId) { mobileSubnavId = null } else { mobileNavOpen = false; openMegaMenu = null }"
@click.outside="if (!$event.target.closest('[data-mega-menu-trigger]')) { openMegaMenu = null } if (!$event.target.closest('[data-search-trigger]')) { searchOpen = false }"
x-trap.inert.noscroll.noautofocus="mobileNavOpen || searchOpen || !!openMegaMenu"
x-cloak
>
{ if (!$el.contains(document.activeElement)) openMegaMenu = null })"
>
Solutions
Explore the connected solutions that help health systems simplify complexity, improve performance, strengthen access, and support growth.
All Solutions
{ if (!$el.contains(document.activeElement)) openMegaMenu = null })"
>
About Us
Learn how Shields connects people, technology, and expertise to advance specialty care for health systems and the patients they serve.
About Us
Oncology
Ambulatory Clinical Pharmacist Impact on Coverage Outcomes for Specialty Onocology Medications
By
Shields Health Solutions
•
November 2nd, 2025
This poster evaluates the impact of an ACP program on third party pharmacy coverage determination outcomes for specialty oncology medications prescribed from these clinics.